Imagion Biosystems Ltd

IBX

Company Profile

  • Business description

    Imagion Biosystems Ltd operates in the field of non-invasive detection of specific solid tumor cancers by use of magnetic nanoparticles. Its principal continuing activities consisted of Nanotechnology; Biotechnology; Cancer Diagnostics; and Medical Imaging using Magnetic Resonance and Superparamagnetic Relaxometry. The company only operating segment - Research and Development. Its principal business activities consist of nanotechnology, biotechnology, cancer diagnostics, and medical imaging using Superparamagnetic Relaxometry. In addition, the company is engaged in the research and development of its clinical phase lead product which is intended for the detection and staging of metastatic HER2 breast cancer.

  • Contact

    96-100 Albert Road
    Level 4
    South MelbourneVIC3205
    AUS

    T: +61 396927222

    https://www.imagionbiosystems.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2025

    Employees

Stocks News & Analysis

stocks

Westpac earnings: Tech overhaul is costly but not hurting lending and deposit growth

Our view after latest earnings report.
stocks

Future Focus: Are franking credits ‘free alpha’?

There’s always an opportunity cost.
stocks

Berkshire Hathaway earnings: Cash balances hit $358 billion on mostly solid results across the firm

We think Berkshire Hathaway stock is moderately undervalued.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,097.6076.40-0.83%
CAC 408,109.7911.28-0.14%
DAX 4024,132.41174.110.73%
Dow JONES (US)47,336.68226.19-0.48%
FTSE 1009,701.3715.88-0.16%
HKSE26,160.462.100.01%
NASDAQ23,834.72109.770.46%
Nikkei 22552,109.01302.33-0.58%
NZX 50 Index13,605.9649.660.37%
S&P 5006,851.9711.770.17%
S&P/ASX 2008,813.8068.90-0.78%
SSE Composite Index3,968.038.49-0.21%

Market Movers